Core Viewpoint - Activist investor Pineal Capital Management is advocating for significant changes at Teladoc Health, including cost reductions and a potential breakup of the company to enhance shareholder value [1][4]. Summary by Sections Shareholder Actions - Pineal Capital has proposed a share repurchase program of at least $200 million, citing that Teladoc's balance sheet is "under-levered" [2]. - The company's stock has decreased by approximately 98% from its peak in February 2021, which Pineal highlighted in its letter to the board, criticizing the absence of share buybacks [2]. Strategic Review and Business Structure - Pineal has called for a comprehensive strategic review, suggesting the exploration of separating Teladoc's two main business units: Integrated Care and BetterHelp, either through a sale or spin-off [3][4]. - The current conglomerate structure is seen as creating a "conglomerate discount," and a breakup could potentially unlock "substantial" value for shareholders [4]. Cost Efficiency and Growth Opportunities - In addition to the split, Pineal is advocating for cost-efficiency measures, particularly as BetterHelp transitions to an insurance-backed model [4]. - The investor has criticized past capital allocation decisions, specifically the 2020 acquisition of Livongo, labeling it as "overvalued" and "ill-timed" [5]. - Pineal also pointed out several growth catalysts, including favorable U.S. policy changes for telehealth reimbursement, the introduction of a 24/7 virtual care platform, and opportunities for international expansion [5].